Clinical trial · Observational
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
A Multicenter Study to Test Digital Breast Tomosynthesis (DBT) Compared to Full-Field Digital Mammography (FFDM) in Detecting Breast Cancer. Part 3. Women Undergoing Breast Biopsy
NCT00535184CI-TRIAL-00006560completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparison of the ability of DBT and FFDM to detect breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women ≥18 years or older and has underwent screening/diagnostic mammography and referred for breast biopsy * Able and willing to comply with study procedures, and have signed and dated the informed consent form * Surgically sterile or postmenopausal Exclusion Criteria: * Pregnant or trying to become pregnant * Has signs or symptoms of breast cancer * Has been previously included in this study * Has breast implants * Has a history of breast cancer and is in active treatment * Has breasts too large to be adequately positioned for the DBT examination
References
Publications (0)
Data not yet available
No reference posted for this study.